YAP1 and triple-A syndrome: In order to determine whether YAP1 participates in the formation of AAA, we applied YAP1 inhibitor‐Verteporfin to block the function of YAP1 in the elastase‐induced and CaCl2‐induced AAA model, and observed the abdominal aortic dilation and aneurysm formation rate.